Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

5.5K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
5.5K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

333
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
333
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

9.2K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
9.2K
Structural Joints: Synovial Joints01:16

Structural Joints: Synovial Joints

5.1K
Synovial joints are the most common type of joint in the body. A key structural characteristic for a synovial joint is the presence of a joint cavity. This fluid-filled space is where the articulating surfaces of the bones contact each other. Also, unlike fibrous or cartilaginous joints, the articulating bone surfaces at a synovial joint are not directly connected to each other with fibrous connective tissue or cartilage. This gives the bones of a synovial joint the ability to move smoothly...
5.1K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

2.2K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms.

Human pathology·2026
Same author

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Thymic hyperplasia with lymphoepithelial sialadenitis-like features A single-institution series of 21 new cases.

Human pathology·2026
Same author

Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy-IASLC MPR Project.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Solid, cystic, and mucinous spindle cell thymomas (WHO type A): A clinicopathological and immunohistochemical study of 7 cases.

Human pathology·2026
Same author

From the archives of MD Anderson Cancer Center: Paraneoplastic autoimmune multiorgan syndrome (PAMS) associated with stroma-rich Castleman disease.

Annals of diagnostic pathology·2026

Related Experiment Video

Updated: Oct 4, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.2K

Primary mediastinal synovial sarcomas.

Katherine Syred1, Annikka Weissferdt2

  • 1Department of Pathology, Derriford Hospital, University Hospitals Plymouth NHS Trust, Plymouth, UK.

Mediastinum (Hong Kong, China)
|February 4, 2022
PubMed
Summary

Mediastinal synovial sarcomas are rare malignant tumors that are difficult to diagnose and often misdiagnosed. This review covers their characteristics, diagnosis, and treatment, highlighting a poorer prognosis compared to extremity sarcomas.

Keywords:
Mediastinumsarcomasynovial sarcomathoracictranslocation

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.3K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.8K

Related Experiment Videos

Last Updated: Oct 4, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.2K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.3K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.8K

Area of Science:

  • Oncology
  • Pathology
  • Medical Imaging

Background:

  • Synovial sarcoma is a rare soft tissue sarcoma, typically affecting young adults in the extremities.
  • Mediastinal synovial sarcomas are exceptionally rare, often misdiagnosed due to lack of specific clinical or imaging features.
  • Unlike extremity tumors, mediastinal variants predominantly affect males and present diagnostic challenges due to histological variability.

Purpose of the Study:

  • To review the clinicopathological, immunohistochemical, and molecular characteristics of rare mediastinal synovial sarcomas.
  • To highlight diagnostic challenges and recent advancements in identifying these neoplasms.
  • To discuss treatment strategies and the prognosis of mediastinal synovial sarcomas.

Main Methods:

  • Review of existing literature on mediastinal synovial sarcomas.
  • Analysis of clinicopathological features, including histology, immunohistochemistry, and molecular techniques.
  • Summary of current treatment modalities and prognostic factors.

Main Results:

  • Mediastinal synovial sarcomas are histologically diverse (monophasic, biphasic, poorly differentiated), complicating diagnosis.
  • Immunohistochemical and molecular analyses are crucial for accurate diagnosis and differentiation from other mediastinal tumors.
  • These tumors often present at a large size, posing challenges for complete surgical resection and leading to a worse prognosis than extremity sarcomas.

Conclusions:

  • Accurate diagnosis of mediastinal synovial sarcoma relies on integrated clinicopathological, immunohistochemical, and molecular data.
  • Multimodal therapy (surgery, chemotherapy, radiation) is typically required for treatment.
  • The prognosis for mediastinal synovial sarcoma is generally poorer due to late diagnosis, large tumor size, and surgical challenges.